These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25860955)

  • 1. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
    Sheu MJ; Hsieh MJ; Chiang WL; Yang SF; Lee HL; Lee LM; Yeh CB
    PLoS One; 2015; 10(4):e0122961. PubMed ID: 25860955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
    Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
    Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A
    J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma.
    Yang Y; Zhou Y; Lu M; An Y; Li R; Chen Y; Lu DR; Jin L; Zhou WP; Qian J; Wang HY
    Mol Carcinog; 2012 Jul; 51(7):515-21. PubMed ID: 21656577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
    Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
    Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population.
    Li QM; Zhang FQ; Li YF; Xian QJ; Zhang YQ; Li P
    Medicine (Baltimore); 2017 Mar; 96(12):e6127. PubMed ID: 28328801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan.
    Li JP; Huang HC; Yang PJ; Chang CY; Chao YH; Tsao TC; Huang H; Hung YC; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32781755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.
    Moazeni-Roodi A; Sarabandi S; Karami S; Hashemi M; Ghavami S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33017009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.
    Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D
    Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
    Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
    Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis.
    Li XD; Li ZG; Song XX; Liu CF
    Pathology; 2010 Dec; 42(7):669-73. PubMed ID: 21080878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.
    Li Y; Zhang W; Doughtie A; Cui G; Li X; Pandit H; Yang Y; Li S; Martin R
    Oncotarget; 2016 Aug; 7(32):52329-52339. PubMed ID: 27447573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
    Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
    World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Functional Genetic Variants of HOTAIR with Hepatocellular Carcinoma (HCC) Susceptibility in a Chinese Population.
    Li H; Tang XM; Liu Y; Li W; Chen Q; Pan Y
    Cell Physiol Biochem; 2017; 44(2):447-454. PubMed ID: 29141248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
    Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
    Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
    Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
    Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma.
    Hsieh YS; Tsai CM; Yeh CB; Yang SF; Hsieh YH; Weng CJ
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S625-33. PubMed ID: 22052111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis.
    Suriapranata IM; Sudania WM; Tjong WY; Suciptan AA; Gani RA; Hasan I; Sanityoso A; Budihusodo U; Miskad UA; Akil F; Lelosutan SA; Martamala R; Yusuf I; Lesmana LA; Sulaiman A; Tai S
    Clin Chim Acta; 2010 Mar; 411(5-6):351-8. PubMed ID: 19968979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.
    Lau HK; Hsieh MJ; Yang SF; Wang HL; Kuo WH; Lee HL; Yeh CB
    Int J Med Sci; 2016; 13(7):556-61. PubMed ID: 27429592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
    Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
    Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.